Update on the clinical use of the low-molecular-weight heparin, parnaparin

References

• AlexanderJHSinghKPInhibition of factor Xa: a potential target for the development of new anticoagulantsAm J Cardiovasc Drugs20055527929016156684
   PubMedGoogle Scholar
• DettoriAGParnaparin: a review of its pharmacological profile and clinical applicationDrugs Today19953111935
   Google Scholar
• FramptonJEFauldsDParnaparin: a review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disordersDrugs19944746526767516862
   PubMed Web of Science ®Google Scholar
• McKeageKKeatingGMParnaparin, A review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disordersDrugs200868110512218081375
   PubMed Web of Science ®Google Scholar
• Fluxum™ Summary of product characteristicsBolognaAlfa Wassermann2007
   Google Scholar
• MaugeriNde GaetanoGBarbantiMPrevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparinHaematologica200590683383915951297
   PubMed Web of Science ®Google Scholar
• MaugeriNDi FabioGBarbantiMParnaparin, a low- molecular-weight heparin, prevents P-select-independent formation of platelet-leukocyte aggregates in human whole bloodThromb Haemost200797696597317549299
   PubMed Web of Science ®Google Scholar
• MelandriGSempriniFCerviVComparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjectsAm J Cardiol19937254504548394644
   PubMed Web of Science ®Google Scholar
• Florian-KujawskiMHoppensteadtDMaddineniJDifferential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins: pharmacologic implicationsInt Angiol200423434635415767980
   PubMed Web of Science ®Google Scholar
• VerhaegheRThe use of low-molecular-weight heparins in cardiovascular diseaseActa Cardiol199853115219638965
   PubMed Web of Science ®Google Scholar
• PalaretiGLegnaniCBianchiniBPharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecologic surgery patientsInt Angiol19898147522768958
   PubMed Web of Science ®Google Scholar
• DettoriAGTagliaferriADall’AglioEClinical pharmacology of a new low molecular weight heparin (alfa LMWH- Fluxum)Int Angiol198873 Suppl7182850327
   PubMed Web of Science ®Google Scholar
• Di StefanoFGiglioAVinciMLow molecular weight heparins for long-term therapy of peripheral vascular diseaseCurr Ther Res1988441110
   Web of Science ®Google Scholar
• SpezialeFVerardiSTaurinoMLow molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgeryPharmatherapeutica1988542612683174726
   PubMedGoogle Scholar
• GarceaDMartuzziFSantelmoNPost-surgical deep vein thrombosis prevention: evaluation of the risk/benefit ratio of fractionated and unfractionated heparinCurr Med Res Opin19921295725831316258
   PubMed Web of Science ®Google Scholar
• ChiapuzzoEOrengoGBOttriaGThe use of low molecular weight heparins for post-surgical deep vein thrombosis prevention in orthopaedic patientsJ Int Med Res19881653593663197913
   PubMed Web of Science ®Google Scholar
• LegnaniCImbertiDCiniMPharmacodynamic of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: a prospective randomised study comparing two different doses of parnaparin [abstract no. P153]Haematologica200691Suppl 289Plus poster presented a the XIX Congress of the Italian Society for Studies on Hemostasis and Thrombosis2006 Sep 14–17Milans
   Google Scholar
• MelandriGBranziASempriniFEffects of two dosages of subcutaneous low molecular weight heparin (parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarctionThromb Res19926623141150
   Web of Science ®Google Scholar
• MannarinoEPasqualiniLInnocenteSEfficacy of low- molecular-weight heparin in the management of intermittent claudicationAngiology1991421171847026
   PubMed Web of Science ®Google Scholar
• CalabròAPiarulliFMilanDClinical assessment of low molecular weight heparin effects in peripheral vascular diseaseAngiology19934431881958382899
   PubMed Web of Science ®Google Scholar
• PRIME CARE Study Investigators GroupComparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE studyIndian Heart J200557664865416521631
   PubMedGoogle Scholar
• ForestieriPQuartoGDe CaterinaMProphylaxis of thromboembolism in bariatric surgery with parnaparinObes Surg200717121558156218004632
   PubMed Web of Science ®Google Scholar
• WangXKZhangYYangCMUse of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarctionClin Drug Invest2006266341349
   PubMed Web of Science ®Google Scholar
• WongGCGiuglianoRPLow-molecular-weight heparins for the treatment of acute coronary syndromesSemin Vasc Med20033439140215199446
   PubMedGoogle Scholar
• DettoriAGBabbiniMHuman pharmacology of a low-molecular-weight heparin (alfa-LMWH): an updateMed Res Rev19921243733891528079
   PubMed Web of Science ®Google Scholar
• AgratiAMAmbrosiGSpinelliGInfluence of the administration site on the bioavailability of a new low molecular weight heparin administered by subcutaneous routeAggiornamenti di Medicina e Chirurgia199193375379
   Google Scholar
• PalmieriGCAmbrosiGFerreroGKinetic control in healthy volunteers of low molecular weight heparin antithrombotic activityRiv Eur Sci Med Farmacol1988101871922856292
   PubMedGoogle Scholar
• ValleISolaGOrigoneAControlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent postoperative deep venous thrombosisCurr Med Res Opin198811280862851413
   PubMed Web of Science ®Google Scholar
• ForzanoFNicoraEAssessment of efficacy and tolerance of a new low molecular weight heparin in post-operative thromboembolic prophylaxisAggior Med Chir1989719
   Google Scholar
• PiniMTagliaferriAManottiCLow molecular weight heparin (alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fracturesInt Angiol1989831341392556484
   PubMed Web of Science ®Google Scholar
• BeghiCFragnitoCAntonelliAPrevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgeryInt Angiol19931243833868207317
   PubMed Web of Science ®Google Scholar
• VerardiSCascianiCUNicoraEA multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosisInt Angiol198873 Suppl19242850322
   PubMed Web of Science ®Google Scholar
• MascaliFCondorelliASalanitiriGPostsurgery thromboembolism prevention by LMW heparin subcutaneous administrationEur Rev Med Pharmacol Sci198810135141
   Google Scholar
• VerardiFCorteseFBaroniBDeep vein thrombosis prevention in surgical patients: effectiveness and safety of a new a low molecular weight heparinCurr Ther Res198946366372
   Web of Science ®Google Scholar
• CataniaGSalanitriGPrevention of postoperative deep vein thrombosis by two different heparin typesInt J Clin Pharmacol198826304309
   PubMedGoogle Scholar
• GruttadauriaGFerraraCMusumeciSSubcutaneous low-molecular weight heparin for postsurgical thromboembolism preventionMed Praxis19889419
   Google Scholar
• SalcuniPFAzzaroneMPalazziniEA new low molecular weight heparin for deep vein thrombosis prevention: effectiveness in postoperative patientsCurr Ther Res198843824831
   Web of Science ®Google Scholar
• CorradoFFiniMSeveriniGLow-molecular weight heparin (Fluxum) prevention of post-operative thrombosis in urological surgery. A controlled studyClin Trials J198826138148
   Google Scholar
• BonomoGMScattarellaMTregliaALPreventing postsurgery thromboembolism by a new low molecular weight heparinMed Praxis19889417
   Google Scholar
• GossettiBIraceLGattusoRPrevention of deep venous thrombosis in vascular surgical procedures by LMW-heparinInter Angio19887Suppl 32527
   PubMed Web of Science ®Google Scholar
• GossettiBIraceLVenosiSLow-molecular weight heparin in prevention of deep vein thrombosis prevention in major vascular surgeryPhlébologie199292456458
   Google Scholar
• PellegrinoABAltaDDe GirolamoCPrevention of post-surgical deep vein thrombosis in urology. Prophylactic use of a new low molecular weight heparinClinical Trials Journal198825164171
   Google Scholar
• CortelliniPPellettiFSimonazziMPPrevention of post-operative thromboembolism. A clinical trial in urological patients treated with a new low molecular weight heparinActa Ther198814135144
   Google Scholar
• TartagliaPPeroloFD’AlesAEffectiveness of prevention with a low molecular weight heparin preparation in gynecological patients undergoing surgery: an open studyCurr Med Res Opin19891163603652539952
   PubMed Web of Science ®Google Scholar
• MontebugnoliMBugamelliSCaloPProphylaxis of venous thromboembolism in minor orthopedic surgery with parnaparinClin Appl Thromb Hemost200713324925817636187
   PubMed Web of Science ®Google Scholar
• NotarbartoloASalanitriGDavìGAvernaMBarbagalloCCatalanoILow-molecular weight heparin in the short and long-term treatment of deep vein thrombosis in diabetic subjectsMed Praxis198894113
   Google Scholar
• TeoldiABotticellaFMalobertiMRAntithrombophilic effect of low molecular weight heparins in patients with deep vein thrombosisClinical Trials Metaanal199328215225
   Google Scholar
• VashistMGKapoorSDhingraAIs low molecular weight heparin effective and safe in the management of deep vein thrombosis? A prospective randomized studyInd Med Gaz2006140175178
   Google Scholar
• BellostaRFerrariPLuzzaniLHome therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrationsAngiology200758331632217626986
   PubMed Web of Science ®Google Scholar
• ZinicolaNCerrutiRDeep vein thrombosis of the lower limbs: results of long term treatment with a new low-molecular weight heparinFarmaci e terapia19893147151
   Google Scholar
• VerardiSIppolitiAPistoleseGRAntithrombotic treatment during acute inflammatory complications of patients affected by postphlebytic syndrome: LMW-heparin versus standard heparinInt Angiol19887Suppl 333402850325
   PubMed Web of Science ®Google Scholar
• SannazzariPLow molecular weight heparin in the symptomatic treatment of chronic venous insufficiency: controlled double blind study vs calcium heparinPanminerva Med19893131271332557572
   PubMed Web of Science ®Google Scholar
• CataniaGSalanitriTHeparin therapy of post-phlebitic syndrome: results of a single-blind, clinical trial of parnaparin vs calcium heparinStampa Medica Europea1993131727
   Google Scholar
• CanovaRCelentanoRGasbarroneLLong-term treatment of patients with post-phlebitic syndrome by means of a new lmw heparinNAM19939318324
   Google Scholar
• Della MarchinaMRenziGRenziCLow molecular weight heparins in chronic venous insufficiency: controlled trial of parnaparin efficacy and tolerabilityBr J Clin Res199342936
   Google Scholar
• MannarinoEPasqualiniLInnocenteSEfficacy of low- molecular-weight heparin in the management of intermittent claudicationAngiology1991421171847026
   PubMed Web of Science ®Google Scholar
• CalabròAPiarulliFMilanDClinical assessment of low molecular weight heparin effects in peripheral vascular diseaseAngiology19934431881958382899
   PubMed Web of Science ®Google Scholar
• SimoniGLucertiniGDecianFLow molecular weight heparins: therapeutic insight in peripheral arterial occlusive diseaseClin Trials Metaanal199328137145
   Google Scholar
• TesiMBronchiGMCAriniAEfficacy and safety of a new low-molecular weight heparin in the medium-term treatment of atherosclerotic arteriopathy of the lower limbsJ Drug Dev198927382
   Google Scholar
• SerraoEMangialardiNTreatment of peripheral arteriopathies with a new low weight heparinPanminerva Medica1991331972041806878
   PubMed Web of Science ®Google Scholar
• PalmieriGAmbrosiGAgratiAMA new low molecular weight heparin in the treatment of peripheral arterial diseaseInt Angiol19887Suppl 341472850326
   PubMed Web of Science ®Google Scholar
• MelandriGSempriniFCerviVBenefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris: a double-blind, randomized, placebo- controlled trialCirculation199388251725238252662
   PubMed Web of Science ®Google Scholar
• PastorelliLSaibeniSSpinaLOral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitisAliment Pharmacol Ther200828558158818700898
   PubMed Web of Science ®Google Scholar
• ImbertiDBaldiniENicoliniAFarmacodinamica dell’eparina a basso peso molecolare in pazienti sottoposti a intervento di chirurgia bariatrica: studio prospettico randomizzato tra due differenti dosi di parnaparin (studio BAFLUX)Atti XVI Congresso Nazionale SICOB2008
   Google Scholar
• AgenoWCattaneoRManfrediEParnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study. Atti XX Congresso Nazionale della Società Italiana per lo Studio dell’Emostasi e della Trombosi (SISET), Firenze, 2008Haematologica200893Suppl 3:33CO98
   Google Scholar
• LuttichauUPalazziniEAntithrombotic therapy in phlebopathies of lower limbs: a controlled study of low molecular weight heparin versus heparin calciumEur Rev Med Pharmacol Sci198911351358
   Google Scholar
• WarkentinTELevineMNHirshJHeparin-induced thrombocytopenia in patients treated with low-molecular- weight heparin or unfractionated heparinN Engl J Med199533220133013357715641
   PubMed Web of Science ®Google Scholar
• PrandoniPSiragusaSGirolamiBThe incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort studyBlood200510693049305416030191
   PubMed Web of Science ®Google Scholar
• GeertsWHPineoGFHeitJAPrevention of venous thromboembolism: the Eightieth ACCP Conference on Anti-thrombotic and Thrombolytic TherapyChest20081336 Suppl381S453S18574271
   PubMed Web of Science ®Google Scholar
• BaglinTBarrowcliffeTWCohenAGuidelines on the use and monitoring of heparin. The British Committee for Standards in HaematologyBr J Haematol20061331193416512825
   PubMed Web of Science ®Google Scholar